id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT03120728
|
1:23:cancer
|
hepatocellular adenoma
| 1
|
[
"hepatocellular",
"adenoma"
] |
[
3,
3
] |
NCT02579096
|
34:77:treatment
|
Patients with a history of prior solid organ / hematopoietic transplantation
| 1
|
[
"Patients",
"with",
"a",
"history",
"of",
"prior",
"solid",
"organ",
"/",
"hematopoietic",
"transplantation"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1
] |
NCT02574910
|
20:30:cancer
|
Evidence of active malignancy
| 1
|
[
"Evidence",
"of",
"active",
"malignancy"
] |
[
0,
0,
0,
3
] |
NCT02169037
|
1:17:chronic_disease
|
vascular disease (1 point)
| 1
|
[
"vascular",
"disease",
"(",
"1",
"point",
")"
] |
[
2,
2,
0,
0,
0,
0
] |
NCT01754857
|
63:71:allergy_name
|
Subjects must not have a known history of hypersensitivity to mannitol
| 1
|
[
"Subjects",
"must",
"not",
"have",
"a",
"known",
"history",
"of",
"hypersensitivity",
"to",
"mannitol"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
4
] |
NCT01976585
|
18:52:chronic_disease
|
Known history of human immunodeficiency virus (HIV)
| 1
|
[
"Known",
"history",
"of",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")"
] |
[
0,
0,
0,
2,
2,
2,
2,
0,
0
] |
NCT02321501
|
,,,143:153:treatment,,
|
Negative serum or urine pregnancy test beta-Human Chorionic Gonadotropin (beta hCG) within 2 weeks prior to receiving the first dose of study medication for women of childbearing age
| 1
|
[
"Negative",
"serum",
"or",
"urine",
"pregnancy",
"test",
"beta-Human",
"Chorionic",
"Gonadotropin",
"(",
"beta",
"hCG",
")",
"within",
"2",
"weeks",
"prior",
"to",
"receiving",
"the",
"first",
"dose",
"of",
"study",
"medication",
"for",
"women",
"of",
"childbearing",
"age"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02012296
|
8:45:chronic_disease
|
Active psychiatric illness/social situations that would limit compliance with protocol requirements
| 1
|
[
"Active",
"psychiatric",
"illness/social",
"situations",
"that",
"would",
"limit",
"compliance",
"with",
"protocol",
"requirements"
] |
[
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02169830
|
1:14:treatment,16:50:treatment,59:69:treatment
|
Nortriptyline: monoamine oxidase inhibitors (MAO) such as phenelzine
| 1
|
[
"Nortriptyline",
":",
"monoamine",
"oxidase",
"inhibitors",
"(",
"MAO",
")",
"such",
"as",
"phenelzine"
] |
[
1,
0,
1,
1,
1,
1,
0,
0,
0,
0,
1
] |
NCT02203513
|
,,196:209:treatment
|
All subjects of reproductive potential must also agree to use both a barrier method and a second method of birth control during the course of the study and for four months after the last dose of study drug(s)
| 1
|
[
"All",
"subjects",
"of",
"reproductive",
"potential",
"must",
"also",
"agree",
"to",
"use",
"both",
"a",
"barrier",
"method",
"and",
"a",
"second",
"method",
"of",
"birth",
"control",
"during",
"the",
"course",
"of",
"the",
"study",
"and",
"for",
"four",
"months",
"after",
"the",
"last",
"dose",
"of",
"study",
"drug",
"(",
"s",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02820350
|
1:4:chronic_disease
|
HIV
| 1
|
[
"HIV"
] |
[
2
] |
NCT00819208
|
15:24:treatment,41:53:treatment,57:66:treatment
|
No concurrent treatment with additional chemotherapy or radiation
| 1
|
[
"No",
"concurrent",
"treatment",
"with",
"additional",
"chemotherapy",
"or",
"radiation"
] |
[
0,
0,
1,
0,
0,
1,
0,
1
] |
NCT01994538
|
29:50:treatment
|
Treatment initiated with an empiric antimicrobial to which the organism isolated in the urine culture is non-susceptible based on standard laboratory criteria
| 1
|
[
"Treatment",
"initiated",
"with",
"an",
"empiric",
"antimicrobial",
"to",
"which",
"the",
"organism",
"isolated",
"in",
"the",
"urine",
"culture",
"is",
"non-susceptible",
"based",
"on",
"standard",
"laboratory",
"criteria"
] |
[
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02593123
|
24:34:cancer
|
Determination that the malignancy is high risk will be made by the investigator
| 1
|
[
"Determination",
"that",
"the",
"malignancy",
"is",
"high",
"risk",
"will",
"be",
"made",
"by",
"the",
"investigator"
] |
[
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01976169
|
20:54:chronic_disease
|
Known positive for human immunodeficiency virus (HIV)
| 1
|
[
"Known",
"positive",
"for",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")"
] |
[
0,
0,
0,
2,
2,
2,
2,
0,
0
] |
NCT02304458
|
,,82:103:treatment,
|
Platelet count >= 75,000/mm^3 (transfusion independent, defined as not receiving platelet transfusions for at least 7 days prior to enrollment)
| 1
|
[
"Platelet",
"count",
">",
"=",
"75,000/mm^3",
"(",
"transfusion",
"independent",
",",
"defined",
"as",
"not",
"receiving",
"platelet",
"transfusions",
"for",
"at",
"least",
"7",
"days",
"prior",
"to",
"enrollment",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01623167
|
1:32:treatment,42:45:treatment,47:58:treatment,73:89:treatment
|
Prior immunosuppressive therapy with any ATG, alemtuzumab, or high dose cyclophosphamide
| 1
|
[
"Prior",
"immunosuppressive",
"therapy",
"with",
"any",
"ATG",
",",
"alemtuzumab",
",",
"or",
"high",
"dose",
"cyclophosphamide"
] |
[
1,
1,
1,
0,
0,
1,
0,
1,
0,
0,
0,
0,
1
] |
NCT02538198
|
34:44:cancer,
|
Diagnosed or treated for another malignancy within 3 years prior to study enrollment
| 1
|
[
"Diagnosed",
"or",
"treated",
"for",
"another",
"malignancy",
"within",
"3",
"years",
"prior",
"to",
"study",
"enrollment"
] |
[
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT02746458
|
,173:192:treatment
|
Additional fracture, dislocations or soft tissue injuries to the study limb that would compromise the ability to weight bear as tolerated and initiate PT within 28 days of definitive fixation
| 1
|
[
"Additional",
"fracture",
",",
"dislocations",
"or",
"soft",
"tissue",
"injuries",
"to",
"the",
"study",
"limb",
"that",
"would",
"compromise",
"the",
"ability",
"to",
"weight",
"bear",
"as",
"tolerated",
"and",
"initiate",
"PT",
"within",
"28",
"days",
"of",
"definitive",
"fixation"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02820350
|
17:39:treatment,56:67:treatment,71:91:treatment,
|
Patients with a solid organ transplant or those with a bone marrow or stem cell transplant in the previous 100 days or who have not engrafted
| 1
|
[
"Patients",
"with",
"a",
"solid",
"organ",
"transplant",
"or",
"those",
"with",
"a",
"bone",
"marrow",
"or",
"stem",
"cell",
"transplant",
"in",
"the",
"previous",
"100",
"days",
"or",
"who",
"have",
"not",
"engrafted"
] |
[
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
1,
1,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01824836
|
102:113:treatment
|
Patients must have adequate hepatic, hematologic and renal functioning to be able to be administered anastrozole at the discretion of the treating physician
| 1
|
[
"Patients",
"must",
"have",
"adequate",
"hepatic",
",",
"hematologic",
"and",
"renal",
"functioning",
"to",
"be",
"able",
"to",
"be",
"administered",
"anastrozole",
"at",
"the",
"discretion",
"of",
"the",
"treating",
"physician"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02379377
|
1:6:cancer
|
Tumor confirmed by arteriography
| 1
|
[
"Tumor",
"confirmed",
"by",
"arteriography"
] |
[
3,
0,
0,
0
] |
NCT02133885
|
6:35:treatment
|
more anti-hypertensive medications of different classes
| 1
|
[
"more",
"anti-hypertensive",
"medications",
"of",
"different",
"classes"
] |
[
0,
1,
1,
0,
0,
0
] |
NCT01953900
|
53:65:treatment
|
Recovered from the acute toxic effects of all prior chemotherapy
| 1
|
[
"Recovered",
"from",
"the",
"acute",
"toxic",
"effects",
"of",
"all",
"prior",
"chemotherapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02400255
|
1:24:treatment,29:36:treatment,40:43:cancer
|
Chemotherapeutic agents for therapy of AML
| 1
|
[
"Chemotherapeutic",
"agents",
"for",
"therapy",
"of",
"AML"
] |
[
1,
1,
0,
1,
0,
3
] |
NCT02106650
|
,,80:89:treatment,
|
Male patients are to agree to use a barrier method of contraception from study treatment initiation until at least 90 days after the last administration of Folotyn
| 1
|
[
"Male",
"patients",
"are",
"to",
"agree",
"to",
"use",
"a",
"barrier",
"method",
"of",
"contraception",
"from",
"study",
"treatment",
"initiation",
"until",
"at",
"least",
"90",
"days",
"after",
"the",
"last",
"administration",
"of",
"Folotyn"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01597518
|
1:18:cancer,33:52:cancer,,103:135:cancer,139:174:cancer
|
Active malignancy or history of invasive malignancy within the last five years, with the exception of superficial basal cell carcinoma or squamous cell carcinoma of the skin that has been definitely treated
| 1
|
[
"Active",
"malignancy",
"or",
"history",
"of",
"invasive",
"malignancy",
"within",
"the",
"last",
"five",
"years",
",",
"with",
"the",
"exception",
"of",
"superficial",
"basal",
"cell",
"carcinoma",
"or",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"skin",
"that",
"has",
"been",
"definitely",
"treated"
] |
[
3,
3,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
0,
3,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0
] |
NCT02236013
|
13:30:treatment,
|
Subject has radiation therapy within 4 weeks prior to the first study dose
| 1
|
[
"Subject",
"has",
"radiation",
"therapy",
"within",
"4",
"weeks",
"prior",
"to",
"the",
"first",
"study",
"dose"
] |
[
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00285935
|
28:53:chronic_disease,55:63:chronic_disease,70:83:chronic_disease
|
Current DSM-5 diagnosis of Major Depressive Disorder, unipolar, with non-psychotic features
| 1
|
[
"Current",
"DSM-5",
"diagnosis",
"of",
"Major",
"Depressive",
"Disorder",
",",
"unipolar",
",",
"with",
"non-psychotic",
"features"
] |
[
0,
0,
0,
0,
2,
2,
2,
0,
2,
0,
0,
2,
0
] |
NCT02254863
|
24:61:treatment
|
Prior participation in any gene or regenerative cell therapy study
| 1
|
[
"Prior",
"participation",
"in",
"any",
"gene",
"or",
"regenerative",
"cell",
"therapy",
"study"
] |
[
0,
0,
0,
1,
1,
1,
1,
1,
1,
0
] |
NCT02416102
|
22:35:chronic_disease
|
clinical evidence of cor pulmonale
| 1
|
[
"clinical",
"evidence",
"of",
"cor",
"pulmonale"
] |
[
0,
0,
0,
2,
2
] |
NCT03113825
|
1:27:treatment,31:41:treatment,44:48:treatment,52:56:treatment,64:74:treatment
|
Primary surgical treatment is lumpectomy + SLNB or ALND --or-- mastectomy + ALND
| 1
|
[
"Primary",
"surgical",
"treatment",
"is",
"lumpectomy",
"+",
"SLNB",
"or",
"ALND",
"--",
"or",
"--",
"mastectomy",
"+",
"ALND"
] |
[
1,
1,
1,
0,
1,
0,
1,
0,
1,
0,
0,
0,
1,
0,
0
] |
NCT02566304
|
1:4:chronic_disease
|
HIV positive
| 1
|
[
"HIV",
"positive"
] |
[
2,
0
] |
NCT02092324
|
,,,,234:251:chronic_disease
|
Subjects with inadequate liver (alanine aminotransferase [ALT]/serum glutamate pyruvate transaminase [SGPT] above 4 X upper limit of normal [ULN] or direct bilirubin 4 X ULN AND the lab abnormalities are felt to be due to underlying liver dysfunction)
| 1
|
[
"Subjects",
"with",
"inadequate",
"liver",
"(",
"alanine",
"aminotransferase",
"[",
"ALT",
"]",
"/serum",
"glutamate",
"pyruvate",
"transaminase",
"[",
"SGPT",
"]",
"above",
"4",
"X",
"upper",
"limit",
"of",
"normal",
"[",
"ULN",
"]",
"or",
"direct",
"bilirubin",
"4",
"X",
"ULN",
"AND",
"the",
"lab",
"abnormalities",
"are",
"felt",
"to",
"be",
"due",
"to",
"underlying",
"liver",
"dysfunction",
")"
] |
[
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03150004
|
,,,,,165:168:cancer,172:188:chronic_disease,192:201:chronic_disease
|
Direct bilirubin ≤ 1.5 X the upper limit of the normal range (ULN), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 3 X ULN unless related to AML or Gilbert syndrome or hemolysis
| 1
|
[
"Direct",
"bilirubin",
"≤",
"1.5",
"X",
"the",
"upper",
"limit",
"of",
"the",
"normal",
"range",
"(",
"ULN",
")",
",",
"alanine",
"aminotransferase",
"(",
"ALT",
")",
"and",
"aspartate",
"aminotransferase",
"(",
"AST",
")",
"≤",
"3",
"X",
"ULN",
"unless",
"related",
"to",
"AML",
"or",
"Gilbert",
"syndrome",
"or",
"hemolysis"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
2,
2,
0,
2
] |
NCT02332850
|
39:57:treatment
|
must be > than four half-lives of the experimental agent
| 1
|
[
"must",
"be",
">",
"than",
"four",
"half-lives",
"of",
"the",
"experimental",
"agent"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02554903
|
,,101:110:treatment
|
Agreement to undertake monthly serum pregnancy tests during the study and up to 30 days after study treatment discontinuation
| 1
|
[
"Agreement",
"to",
"undertake",
"monthly",
"serum",
"pregnancy",
"tests",
"during",
"the",
"study",
"and",
"up",
"to",
"30",
"days",
"after",
"study",
"treatment",
"discontinuation"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT01434316
|
76:84:treatment,130:144:treatment,130:135:cancer,160:166:treatment,288:297:allergy_name,392:407:treatment,429:437:treatment,441:469:treatment,510:533:treatment,,,,,653:675:treatment
|
Eligible patients in the dose escalation phases of the trial must agree to biopsies of normal skin, unless they undergo optional tumor biopsies; the mandatory biopsy requirement can be waived at the discretion of principal investigator in the event of any medical contraindication (e.g. lidocaine allergy); patients enrolled to the expanded cohorts must agree to tumor sampling; patients on anticoagulation must be able to hold warfarin or low molecular weight heparin for a sufficient amount of time to make skin and tumor biopsies safe to perform; PT/INR and PTT should be =< 1.5 times the institutional upper limit of normal prior to performance of skin or tumor biopsies, with values re-checked after the eligibility screen as medically indicated
| 1
|
[
"Eligible",
"patients",
"in",
"the",
"dose",
"escalation",
"phases",
"of",
"the",
"trial",
"must",
"agree",
"to",
"biopsies",
"of",
"normal",
"skin",
",",
"unless",
"they",
"undergo",
"optional",
"tumor",
"biopsies",
";",
"the",
"mandatory",
"biopsy",
"requirement",
"can",
"be",
"waived",
"at",
"the",
"discretion",
"of",
"principal",
"investigator",
"in",
"the",
"event",
"of",
"any",
"medical",
"contraindication",
"(",
"e.g",
".",
"lidocaine",
"allergy",
")",
";",
"patients",
"enrolled",
"to",
"the",
"expanded",
"cohorts",
"must",
"agree",
"to",
"tumor",
"sampling",
";",
"patients",
"on",
"anticoagulation",
"must",
"be",
"able",
"to",
"hold",
"warfarin",
"or",
"low",
"molecular",
"weight",
"heparin",
"for",
"a",
"sufficient",
"amount",
"of",
"time",
"to",
"make",
"skin",
"and",
"tumor",
"biopsies",
"safe",
"to",
"perform",
";",
"PT/INR",
"and",
"PTT",
"should",
"be",
"=",
"<",
"1.5",
"times",
"the",
"institutional",
"upper",
"limit",
"of",
"normal",
"prior",
"to",
"performance",
"of",
"skin",
"or",
"tumor",
"biopsies",
",",
"with",
"values",
"re-checked",
"after",
"the",
"eligibility",
"screen",
"as",
"medically",
"indicated"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1,
1,
1,
1,
0,
0,
3,
1,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
4,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
1,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02439450
|
89:102:treatment,125:138:treatment,141:151:treatment
|
radiographically per RECIST 1.1 at first imaging assessment, and will begin maintenance immunotherapy with standard of care pembrolizumab ± pemetrexed
| 1
|
[
"radiographically",
"per",
"RECIST",
"1.1",
"at",
"first",
"imaging",
"assessment",
",",
"and",
"will",
"begin",
"maintenance",
"immunotherapy",
"with",
"standard",
"of",
"care",
"pembrolizumab",
"±",
"pemetrexed"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
1,
0,
1
] |
NCT02397083
|
9:22:chronic_disease
|
Genital actinomycosis
| 1
|
[
"Genital",
"actinomycosis"
] |
[
0,
2
] |
NCT01763970
|
1:19:cancer
|
tumor malignancies must meet certain criteria to be eligible
| 1
|
[
"tumor",
"malignancies",
"must",
"meet",
"certain",
"criteria",
"to",
"be",
"eligible"
] |
[
3,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT03165227
|
11:24:treatment
|
bilateral salpingectomy
| 1
|
[
"bilateral",
"salpingectomy"
] |
[
0,
1
] |
NCT02263274
|
7:23:allergy_name
|
Known adhesive allergy
| 1
|
[
"Known",
"adhesive",
"allergy"
] |
[
0,
4,
4
] |
NCT02514083
|
1:24:chronic_disease
|
Impaired renal function
| 1
|
[
"Impaired",
"renal",
"function"
] |
[
2,
2,
2
] |
NCT02804230
|
1:39:chronic_disease
|
Lesions in the brainstem or cerebellum
| 1
|
[
"Lesions",
"in",
"the",
"brainstem",
"or",
"cerebellum"
] |
[
2,
2,
2,
2,
2,
2
] |
NCT01703949
|
,63:75:treatment
|
Patients must be anticipated to complete at least 2 cycles of chemotherapy on study
| 1
|
[
"Patients",
"must",
"be",
"anticipated",
"to",
"complete",
"at",
"least",
"2",
"cycles",
"of",
"chemotherapy",
"on",
"study"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0
] |
NCT02998918
|
21:44:treatment,48:65:treatment,82:94:chronic_disease
|
Taking prescription anti-inflammatory drugs or supplements/drugs that may affect inflammation
| 1
|
[
"Taking",
"prescription",
"anti-inflammatory",
"drugs",
"or",
"supplements/drugs",
"that",
"may",
"affect",
"inflammation"
] |
[
0,
0,
1,
1,
0,
1,
0,
0,
0,
2
] |
NCT02474199
|
85:97:treatment,,
|
For subjects with elevated liver tests as defined above, local pathology reading of liver biopsy 6-10 days after darTregs infusion is without AR according to Banff criteria
| 1
|
[
"For",
"subjects",
"with",
"elevated",
"liver",
"tests",
"as",
"defined",
"above",
",",
"local",
"pathology",
"reading",
"of",
"liver",
"biopsy",
"6-10",
"days",
"after",
"darTregs",
"infusion",
"is",
"without",
"AR",
"according",
"to",
"Banff",
"criteria"
] |
[
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01964404
|
22:31:chronic_disease,,
|
Positive symptoms of psychosis (> 4 [moderate]) on any item of the Positive and Negative Syndrome Scale psychosis subscale (once abstinent) except for the hallucination item
| 1
|
[
"Positive",
"symptoms",
"of",
"psychosis",
"(",
">",
"4",
"[",
"moderate",
"]",
")",
"on",
"any",
"item",
"of",
"the",
"Positive",
"and",
"Negative",
"Syndrome",
"Scale",
"psychosis",
"subscale",
"(",
"once",
"abstinent",
")",
"except",
"for",
"the",
"hallucination",
"item"
] |
[
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03137758
|
18:48:treatment
|
standard of care androgen deprivation treatment
| 1
|
[
"standard",
"of",
"care",
"androgen",
"deprivation",
"treatment"
] |
[
0,
0,
0,
1,
1,
1
] |
NCT02566304
|
55:65:cancer
|
Active involvement of the central nervous system with malignancy
| 1
|
[
"Active",
"involvement",
"of",
"the",
"central",
"nervous",
"system",
"with",
"malignancy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
3
] |
NCT03179397
|
17:34:chronic_disease,42:52:chronic_disease,66:87:chronic_disease
|
Clinical severe corneal dystrophy (e.g., epithelial, stromal, or endothelial dystrophy)
| 1
|
[
"Clinical",
"severe",
"corneal",
"dystrophy",
"(",
"e.g.",
",",
"epithelial",
",",
"stromal",
",",
"or",
"endothelial",
"dystrophy",
")"
] |
[
0,
0,
2,
2,
0,
0,
0,
2,
0,
0,
0,
0,
2,
2,
0
] |
NCT02536794
|
,36:48:treatment
|
have received at least one line of chemotherapy in the metastatic setting
| 1
|
[
"have",
"received",
"at",
"least",
"one",
"line",
"of",
"chemotherapy",
"in",
"the",
"metastatic",
"setting"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT03113136
|
51:62:chronic_disease,64:70:chronic_disease,75:88:chronic_disease
|
unstable or significant medical condition such as respiratory, kidney, or liver disease that could potentially affect biomarker data
| 1
|
[
"unstable",
"or",
"significant",
"medical",
"condition",
"such",
"as",
"respiratory",
",",
"kidney",
",",
"or",
"liver",
"disease",
"that",
"could",
"potentially",
"affect",
"biomarker",
"data"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT03175978
|
16:24:chronic_disease,30:46:chronic_disease,66:74:chronic_disease
|
Any history of epilepsy or a seizure disorder or any known prior seizures
| 1
|
[
"Any",
"history",
"of",
"epilepsy",
"or",
"a",
"seizure",
"disorder",
"or",
"any",
"known",
"prior",
"seizures"
] |
[
0,
0,
0,
2,
0,
0,
2,
2,
0,
0,
0,
0,
2
] |
NCT02227199
|
35:69:chronic_disease
|
Patients known to be positive for human immunodeficiency virus (HIV)
| 1
|
[
"Patients",
"known",
"to",
"be",
"positive",
"for",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")"
] |
[
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0
] |
NCT02963831
|
15:33:cancer,50:77:treatment,114:139:cancer,143:177:cancer
|
Subjects with peritoneal disease who have failed prior standard chemotherapy and have histologic confirmation of epithelial ovarian cancer or metastatic colorectal cancer (CRC) including cancer originating from the appendix
| 1
|
[
"Subjects",
"with",
"peritoneal",
"disease",
"who",
"have",
"failed",
"prior",
"standard",
"chemotherapy",
"and",
"have",
"histologic",
"confirmation",
"of",
"epithelial",
"ovarian",
"cancer",
"or",
"metastatic",
"colorectal",
"cancer",
"(",
"CRC",
")",
"including",
"cancer",
"originating",
"from",
"the",
"appendix"
] |
[
0,
0,
3,
3,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
3,
3,
3,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02334865
|
11:31:chronic_disease,42:51:treatment,55:80:treatment
|
Any prior autoimmune disorders requiring cytotoxic or immunosuppressive therapy or autoimmune disorders with visceral involvement
| 1
|
[
"Any",
"prior",
"autoimmune",
"disorders",
"requiring",
"cytotoxic",
"or",
"immunosuppressive",
"therapy",
"or",
"autoimmune",
"disorders",
"with",
"visceral",
"involvement"
] |
[
0,
0,
2,
2,
0,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT03187028
|
1:26:chronic_disease
|
severe emotional distress
| 1
|
[
"severe",
"emotional",
"distress"
] |
[
2,
2,
2
] |
NCT01618357
|
14:26:treatment,19:26:treatment,28:41:treatment,43:59:treatment,64:87:treatment,,138:147:treatment,152:161:treatment
|
Last dose of chemotherapy, immunotherapy, biologic therapy, or investigational therapy, was less than 14 days prior to protocol therapy (radiation and veliparib)
| 1
|
[
"Last",
"dose",
"of",
"chemotherapy",
",",
"immunotherapy",
",",
"biologic",
"therapy",
",",
"or",
"investigational",
"therapy",
",",
"was",
"less",
"than",
"14",
"days",
"prior",
"to",
"protocol",
"therapy",
"(",
"radiation",
"and",
"veliparib",
")"
] |
[
0,
0,
0,
1,
0,
1,
0,
1,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0
] |
NCT02573246
|
1:24:chronic_disease
|
Intellectual disability
| 1
|
[
"Intellectual",
"disability"
] |
[
2,
2
] |
NCT01873131
|
48:57:treatment
|
whose parent/guardian is unable to comply with treatment, home care or follow-up visits
| 1
|
[
"whose",
"parent/guardian",
"is",
"unable",
"to",
"comply",
"with",
"treatment",
",",
"home",
"care",
"or",
"follow-up",
"visits"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT01962415
|
8:32:chronic_disease
|
Severe acquired aplastic anemia
| 1
|
[
"Severe",
"acquired",
"aplastic",
"anemia"
] |
[
0,
2,
2,
2
] |
NCT02085941
|
36:51:cancer,60:70:cancer
|
must have histologically confirmed malignant tumor that is metastatic or unresectable and for which standard curative or palliative measures do not exist or are no longer effective
| 1
|
[
"must",
"have",
"histologically",
"confirmed",
"malignant",
"tumor",
"that",
"is",
"metastatic",
"or",
"unresectable",
"and",
"for",
"which",
"standard",
"curative",
"or",
"palliative",
"measures",
"do",
"not",
"exist",
"or",
"are",
"no",
"longer",
"effective"
] |
[
0,
0,
0,
0,
3,
3,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03003780
|
1:24:chronic_disease
|
COPD or HF exacerbation in the previous month
| 1
|
[
"COPD",
"or",
"HF",
"exacerbation",
"in",
"the",
"previous",
"month"
] |
[
2,
2,
2,
2,
0,
0,
0,
0
] |
NCT02706249
|
13:25:chronic_disease,,,
|
Presence of coagulopathy (PT or PTT> 1.2 x upper limit of normal)
| 1
|
[
"Presence",
"of",
"coagulopathy",
"(",
"PT",
"or",
"PTT",
">",
"1.2",
"x",
"upper",
"limit",
"of",
"normal",
")"
] |
[
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01660607
|
1:12:chronic_disease
|
hepatitis B sAg
| 1
|
[
"hepatitis",
"B",
"sAg"
] |
[
2,
2,
0
] |
NCT02555189
|
12:21:chronic_disease,25:44:chronic_disease,74:83:chronic_disease,87:108:chronic_disease
|
History of pituitary or adrenal dysfunction, active or symptomatic viral hepatitis or chronic liver disease
| 1
|
[
"History",
"of",
"pituitary",
"or",
"adrenal",
"dysfunction",
",",
"active",
"or",
"symptomatic",
"viral",
"hepatitis",
"or",
"chronic",
"liver",
"disease"
] |
[
0,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
2,
0,
2,
2,
2
] |
NCT02575404
|
117:130:treatment
|
Patients who have radiographic progression using Response Evaluation Criteria In Solid Tumors (RECIST) currently on pembrolizumab are also eligible
| 1
|
[
"Patients",
"who",
"have",
"radiographic",
"progression",
"using",
"Response",
"Evaluation",
"Criteria",
"In",
"Solid",
"Tumors",
"(",
"RECIST",
")",
"currently",
"on",
"pembrolizumab",
"are",
"also",
"eligible"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02551679
|
39:72:chronic_disease
|
Severe concurrent disease (other than Peripheral Vascular Disease (PAD)
| 1
|
[
"Severe",
"concurrent",
"disease",
"(",
"other",
"than",
"Peripheral",
"Vascular",
"Disease",
"(",
"PAD",
")"
] |
[
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0
] |
NCT03037385
|
39:61:chronic_disease
|
Clinically significant, uncontrolled, cardiovascular disease
| 1
|
[
"Clinically",
"significant",
",",
"uncontrolled",
",",
"cardiovascular",
"disease"
] |
[
0,
0,
0,
0,
0,
2,
2
] |
NCT02091999
|
1:13:treatment
|
chemotherapy
| 1
|
[
"chemotherapy"
] |
[
1
] |
NCT03008603
|
26:38:chronic_disease
|
Subject with significant coagulopathy
| 1
|
[
"Subject",
"with",
"significant",
"coagulopathy"
] |
[
0,
0,
0,
2
] |
NCT02339948
|
9:16:chronic_disease,20:39:chronic_disease,64:73:treatment
|
Current medical or psychiatric illness that may interfere with treatment completion and followup
| 1
|
[
"Current",
"medical",
"or",
"psychiatric",
"illness",
"that",
"may",
"interfere",
"with",
"treatment",
"completion",
"and",
"followup"
] |
[
0,
2,
0,
2,
2,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02515110
|
,,135:144:treatment
|
Women of child-bearing potential (WCBP) must agree to use a medically accepted form of pregnancy prevention for the duration of study treatment
| 1
|
[
"Women",
"of",
"child-bearing",
"potential",
"(",
"WCBP",
")",
"must",
"agree",
"to",
"use",
"a",
"medically",
"accepted",
"form",
"of",
"pregnancy",
"prevention",
"for",
"the",
"duration",
"of",
"study",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02488967
|
1:45:treatment,,74:92:treatment,115:131:treatment
|
Chronic daily treatment with corticosteroids with a dose of >= 10 mg/day methylprednisolone equivalent (excluding inhaled steroids)
| 1
|
[
"Chronic",
"daily",
"treatment",
"with",
"corticosteroids",
"with",
"a",
"dose",
"of",
">",
"=",
"10",
"mg/day",
"methylprednisolone",
"equivalent",
"(",
"excluding",
"inhaled",
"steroids",
")"
] |
[
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
1,
1,
0
] |
NCT01983462
|
8:24:treatment,26:34:treatment,36:41:treatment,51:62:treatment,64:72:treatment,74:81:treatment,83:92:treatment
|
Taking cox-2 inhibitors (Celebrex, Vioxx, etc) or allopurinol (Zyloprim, Lopurin, Allopurin)
| 1
|
[
"Taking",
"cox-2",
"inhibitors",
"(",
"Celebrex",
",",
"Vioxx",
",",
"etc",
")",
"or",
"allopurinol",
"(",
"Zyloprim",
",",
"Lopurin",
",",
"Allopurin",
")"
] |
[
0,
1,
1,
0,
1,
0,
1,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0
] |
NCT01614990
|
8:18:chronic_disease
|
Severe depression as determined by the investigator
| 1
|
[
"Severe",
"depression",
"as",
"determined",
"by",
"the",
"investigator"
] |
[
0,
2,
0,
0,
0,
0,
0
] |
NCT02776761
|
5:20:treatment,,
|
For corticosteroids, this will mean prednisone, or equivalent, greater than or equal to 0.5 mg/kg/day
| 1
|
[
"For",
"corticosteroids",
",",
"this",
"will",
"mean",
"prednisone",
",",
"or",
"equivalent",
",",
"greater",
"than",
"or",
"equal",
"to",
"0.5",
"mg/kg/day"
] |
[
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02323191
|
31:55:cancer,
|
Participants has a history of hematological malignancy within the last 5 years prior to study entry
| 1
|
[
"Participants",
"has",
"a",
"history",
"of",
"hematological",
"malignancy",
"within",
"the",
"last",
"5",
"years",
"prior",
"to",
"study",
"entry"
] |
[
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02031250
|
15:31:chronic_disease
|
Patients with active infection
| 1
|
[
"Patients",
"with",
"active",
"infection"
] |
[
0,
0,
2,
2
] |
NCT02120222
|
14:30:chronic_disease
|
Uncontrolled active infection within one week prior to first dose
| 1
|
[
"Uncontrolled",
"active",
"infection",
"within",
"one",
"week",
"prior",
"to",
"first",
"dose"
] |
[
0,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT01512888
|
,,36:45:treatment,71:91:treatment,108:138:treatment
|
Less than 300 CD3+ T-cells by flow cytometry or higher if evidence of maternal engraftment as supported by peripheral blood FISH analysis for XY and XX
| 1
|
[
"Less",
"than",
"300",
"CD3+",
"T-cells",
"by",
"flow",
"cytometry",
"or",
"higher",
"if",
"evidence",
"of",
"maternal",
"engraftment",
"as",
"supported",
"by",
"peripheral",
"blood",
"FISH",
"analysis",
"for",
"XY",
"and",
"XX"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0
] |
NCT02393157
|
56:94:cancer
|
Patients in first relapse or primary induction failure CD20 positive B-cell leukemia/lymphoma
| 1
|
[
"Patients",
"in",
"first",
"relapse",
"or",
"primary",
"induction",
"failure",
"CD20",
"positive",
"B-cell",
"leukemia/lymphoma"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3
] |
NCT02474199
|
31:57:cancer,65:76:cancer,78:83:cancer,87:100:cancer
|
History of adequately treated in-situ cervical carcinoma and/or skin cancer (basal or squamous cell) will be permitted
| 1
|
[
"History",
"of",
"adequately",
"treated",
"in-situ",
"cervical",
"carcinoma",
"and/or",
"skin",
"cancer",
"(",
"basal",
"or",
"squamous",
"cell",
")",
"will",
"be",
"permitted"
] |
[
0,
0,
0,
0,
3,
3,
3,
0,
3,
3,
0,
3,
0,
3,
3,
0,
0,
0,
0
] |
NCT00739362
|
1:31:chronic_disease,33:58:chronic_disease,60:68:chronic_disease,70:97:chronic_disease,99:107:chronic_disease,122:133:chronic_disease
|
Central nervous system disease (cerebrovascular accidents, dementia, neurodegenerative disorders, epilepsy or history of head injury)
| 1
|
[
"Central",
"nervous",
"system",
"disease",
"(",
"cerebrovascular",
"accidents",
",",
"dementia",
",",
"neurodegenerative",
"disorders",
",",
"epilepsy",
"or",
"history",
"of",
"head",
"injury",
")"
] |
[
2,
2,
2,
2,
0,
2,
2,
0,
2,
0,
2,
2,
0,
2,
0,
0,
0,
2,
2,
0
] |
NCT00357565
|
,84:100:treatment,,
|
All patients must be in CR as defined by hematological recovery, AND <5% blasts by light microscopy within the bone marrow with a cellularity of ≥15%
| 1
|
[
"All",
"patients",
"must",
"be",
"in",
"CR",
"as",
"defined",
"by",
"hematological",
"recovery",
",",
"AND",
"<",
"5",
"%",
"blasts",
"by",
"light",
"microscopy",
"within",
"the",
"bone",
"marrow",
"with",
"a",
"cellularity",
"of",
"≥15",
"%"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03004170
|
96:99:chronic_disease,
|
Report engaging in one or more occasions of condomless anal and/or vaginal intercourse with an HIV-negative or unknown HIV serostatus sex partner in the 3 months prior to study enrollment
| 1
|
[
"Report",
"engaging",
"in",
"one",
"or",
"more",
"occasions",
"of",
"condomless",
"anal",
"and/or",
"vaginal",
"intercourse",
"with",
"an",
"HIV-negative",
"or",
"unknown",
"HIV",
"serostatus",
"sex",
"partner",
"in",
"the",
"3",
"months",
"prior",
"to",
"study",
"enrollment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03132415
|
1:4:chronic_disease
|
HIV-positive
| 1
|
[
"HIV-positive"
] |
[
2
] |
NCT02833792
|
12:29:cancer
|
History of cerebral neoplasm
| 1
|
[
"History",
"of",
"cerebral",
"neoplasm"
] |
[
0,
0,
3,
3
] |
NCT02350764
|
57:85:treatment
|
There is no restriction on the number of prior lines of systemic anti-cancer therapy
| 1
|
[
"There",
"is",
"no",
"restriction",
"on",
"the",
"number",
"of",
"prior",
"lines",
"of",
"systemic",
"anti-cancer",
"therapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02131467
|
1:10:treatment
|
efavirenz
| 1
|
[
"efavirenz"
] |
[
1
] |
NCT00670358
|
,,,,80:88:cancer
|
Alkaline phosphatase ≤ 3 times ULN (5 times ULN if direct liver involvement by lymphoma)
| 1
|
[
"Alkaline",
"phosphatase",
"≤",
"3",
"times",
"ULN",
"(",
"5",
"times",
"ULN",
"if",
"direct",
"liver",
"involvement",
"by",
"lymphoma",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0
] |
NCT01754779
|
,,36:59:chronic_disease
|
high pH as >6.40 in the absence of urinary tract infection
| 1
|
[
"high",
"pH",
"as",
">",
"6.40",
"in",
"the",
"absence",
"of",
"urinary",
"tract",
"infection"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT02253316
|
22:39:chronic_disease
|
clinically important autonomic disease
| 1
|
[
"clinically",
"important",
"autonomic",
"disease"
] |
[
0,
0,
2,
2
] |
NCT02844907
|
13:28:chronic_disease
|
Significant hepatic disease
| 1
|
[
"Significant",
"hepatic",
"disease"
] |
[
0,
2,
2
] |
NCT03001882
|
25:58:cancer
|
Patients with untreated central nervous system metastases
| 1
|
[
"Patients",
"with",
"untreated",
"central",
"nervous",
"system",
"metastases"
] |
[
0,
0,
0,
3,
3,
3,
3
] |
NCT01994382
|
24:42:cancer,38:42:cancer,39:42:cancer,95:98:cancer,99:101:cancer,103:106:cancer,109:113:cancer,126:131:cancer,133:144:cancer,146:149:cancer,194:197:cancer,198:201:cancer,203:207:cancer,212:216:cancer,223:225:cancer,226:228:cancer
|
Histological evidence: FL Grade 1-3A/iNHL, with relapsed or refractory disease (iNHL includes LPL/WM, MZL); aNHL, defined as DLBCL, FL Grade 3B, MCL, and transformed NHL with relapsed disease; CLL/SLL, PTCL, or CTCL (with MF/SS) with relapsed or refractory
| 1
|
[
"Histological",
"evidence",
":",
"FL",
"Grade",
"1-3A/iNHL",
",",
"with",
"relapsed",
"or",
"refractory",
"disease",
"(",
"iNHL",
"includes",
"LPL/WM",
",",
"MZL",
")",
";",
"aNHL",
",",
"defined",
"as",
"DLBCL",
",",
"FL",
"Grade",
"3B",
",",
"MCL",
",",
"and",
"transformed",
"NHL",
"with",
"relapsed",
"disease",
";",
"CLL/SLL",
",",
"PTCL",
",",
"or",
"CTCL",
"(",
"with",
"MF/SS",
")",
"with",
"relapsed",
"or",
"refractory"
] |
[
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
3,
0,
0,
3,
0,
0,
0,
3,
0,
0,
0,
0,
0,
3,
0,
0,
0,
3,
0,
0,
0,
0,
3,
0,
3,
0,
0,
3,
0,
0,
3,
0,
0,
0,
0,
0
] |
NCT02474199
|
9:27:cancer
|
without cholangiocarcinoma morphology
| 1
|
[
"without",
"cholangiocarcinoma",
"morphology"
] |
[
0,
3,
0
] |
NCT02606045
|
1:8:treatment,
|
Surgery within the past 8 weeks
| 1
|
[
"Surgery",
"within",
"the",
"past",
"8",
"weeks"
] |
[
1,
0,
0,
0,
0,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.